Senior insider sale
General Counsel and Secretary at CRISPR THERAPEUTICS AG — senior position signals high conviction
$626.5K
10.40K shares
What this filing means
KASINGER JAMES R. plans to sell 10.40K shares of CRISPR THERAPEUTICS AG valued at approximately $626.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/22/2026ACC: 0001950047-26-009755
Officer· General Counsel and Secretary
Since Feb 2026
10.40K
Shares to sell
$626.5K
Approx. market value
10.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/22/2026
10.40KTotal acquired10.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/22/2026 | Stock Option Exercise Cash | 10.40K | — |
| Total | 10.40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.40K
Market value
$626.5K
9/22/2026
Total
Units
10.40K
Value
$626.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/22/2026 | 10.40K | $626.5K | NASDAQ | Planned |
| Total | 10.40K | $626.5K | ||